Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Centrexion Therapeutics
AddedFeb 13, 2024
UpdatedJun 18, 2026
Centrexion Therapeutics

Centrexion Therapeutics

Public

US-based Centrexion Therapeutics develops non-opioid, non-addictive therapies for chronic pain treatment.

HQ
Boston, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees

Centrexion Therapeutics is a late clinical-stage biopharmaceutical company dedicated to developing and commercializing novel, non-opioid, and non-addictive therapies for chronic pain. Their mission is to address the significant unmet medical need in pain management, offering safer alternatives to traditional opioid treatments.

Centrexion Therapeutics has made significant strides in the biopharmaceutical industry, advancing several promising candidates through clinical trials. Their innovative approach has the potential to transform chronic pain treatment, providing relief without the risks associated with opioids.

Centrexion Therapeutics - Similar Companies

Concentric Analgesics logo

Concentric Analgesics

Trigemina logo

Trigemina

Tremeau Pharmaceuticals logo

Tremeau Pharmaceuticals

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

Maxona Pharmaceuticals logo

Maxona Pharmaceuticals

maxonapharm.com

Quartet Medicine logo

Quartet Medicine

Phoenix PharmaLabs logo

Phoenix PharmaLabs

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Solace Pharmaceuticals logo

Solace Pharmaceuticals

Sarentis Therapeutics logo

Sarentis Therapeutics

Cmxtwenty logo

Cmxtwenty

Spine BioPharma logo

Spine BioPharma

spinebiopharma.com

Neuropathix logo

Neuropathix

neuropathix.com

Sollis Therapeutics logo

Sollis Therapeutics

Vapogenix logo

Vapogenix

vapogenix.com

Centrexion Therapeutics - Quick Facts

Who are Centrexion Therapeutics' competitors?

Companies similar to Centrexion Therapeutics include Concentric Analgesics, Trigemina, Tremeau Pharmaceuticals and Latigo Biotherapeutics.

When was Centrexion Therapeutics founded?

Centrexion Therapeutics was founded in 2013.

Where is Centrexion Therapeutics' headquarters located?

Centrexion Therapeutics' headquarters is located in Boston, MA, US.

How much has Centrexion Therapeutics raised to-date?

As of Oct 29, 2020, Centrexion Therapeutics has raised a total of $229.2M (USD).

How many employees does Centrexion Therapeutics have?

Centrexion Therapeutics has 22 employees as of Feb 5, 2024.

Centrexion Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pain Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research